Lung function in children with congenital heart defects, early after heart surgery Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing Year: 2007
Prolonged mechanical ventilation among children with congenital heart disease undergoing cardiac surgery in Philippine heart center: A risk factors analysis Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010
Postoperative pulmonary complication following paediatric open heart corrective surgery for congenital heart diseases: a Philippine heart center experience Source: Eur Respir J 2001; 18: Suppl. 33, 457s Year: 2001
Predicting risk of postoperative pulmonary complications in children and adolescents with congenital heart defects after surgical repair Source: Annual Congress 2004 - Premature infants, respiratory morbidity and lung pathology in children Year: 2004
Impact of cardiac bypass and aortic clamping on functional residual capacity in children undergoing surgical repair of congenital heart disease Source: Eur Respir J 2006; 28: Suppl. 50, 704s Year: 2006
Changes in airway and respiratory tissue mechanics following surgical repair of congenital heart disease in children Source: Eur Respir J 2002; 20: Suppl. 38, 138s Year: 2002
Tracheobronchoscopy in the management of paediatric patients with congenital heart defects Source: Eur Respir J 2003; 22: Suppl. 45, 320s Year: 2003
Effect of short-term oxygen therapy on exercise performance in patients with cyanotic congenital heart disease Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021
Changes of lung function in infants with congenital heart disease and univentricular circulation Source: Eur Respir J 2004; 24: Suppl. 48, 159s Year: 2004
The role of cardiopulmonary exercise testing in assessment of the severity of patients with PAH associated with congenital heart disease. Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019
Double combination therapy in patients with pulmonary arterial hypertension associated with congenital heart defects Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011
Genetic risk factors for laterality defects and congenital heart disease (CHD) in patients with primary ciliary dyskinesia (PCD) Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution Year: 2017
Investigation of pulmonary function tests and respiratory muscle strength in patients who have undergone valvular heart surgery Source: Eur Respir J 2005; 26: Suppl. 49, 496s Year: 2005
Our experience in natural surfactant administration for prevention of respiratory failure after cardiac surgery procedures Source: Eur Respir J 2004; 24: Suppl. 48, 205s Year: 2004
Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD) Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation Source: Eur Respir J 2003; 22: 47S-56S Year: 2003
Adult congenital heart disease and pulmonary hypertension: management of a complex case Source: Eur Respir Rev 2012 21: 362-364 Year: 2012
Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH) Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006
Chest physiotherapy in newborns with congenital heart disease after cardiac surgery Source: Eur Respir J 2002; 20: Suppl. 38, 350s Year: 2002
Lung function in children with congenital heart disease Source: International Congress 2018 – Insights in primary ciliary dyskinesia, asthma and lung function testing Year: 2018